HCPCS code J9298 — Inj nivol relatlimab 3mg/1mg. Status: Active. Effective Oct 1, 2022. Source: CMS HCPCS Level II.

J9298

Active

Inj nivol relatlimab 3mg/1mg

Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Oct 1, 2022
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9057

MUE — Medically Unlikely Edits

Maximum units of J9298 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 160
Practitioner Services 160

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
00003-7125-11 Opdualag

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2022-Q4
    Inj nivol relatlimab 3mg/1mg